Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 43,007 $ 14,907
Restricted cash 1,108 957
Other current assets 2,986 1,768
Total current assets 47,101 17,632
Non-current assets    
Operating lease right-of-use assets 11,279 3,495
Property and equipment, net 7,438 3,902
In-process Research and development (“IPR&D”) assets and Goodwill 15,788
Total non-current assets 34,505 7,397
Total Assets 81,606 25,029
Current liabilities    
Trade accounts payable 3,686 1,381
Current portion of lease liabilities 985 666
Other accounts payable 6,036 3,344
Current portion of long-term debt 5,785
Total current liabilities 10,707 11,176
Non-current liabilities    
Contract liability 1,976 1,976
Long-term debt, net of current portion 5,402
Operating lease liabilities, net of current portion 9,139 3,239
Other liabilities 153 155
Private Placement Warrants 36,755
Total non-current liabilities 48,023 10,772
Commitments and Contingencies (Note 7)
Redeemable Convertible Preferred Shares    
Preferred Stock, $0.0001 par value; Authorized - 1,000,000 shares as of March 31, 2024 and December 31, 2023. Issued and outstanding- 256,887 as of March 31, 2024. No shares issued and outstanding as of December 31, 2023. 32,420
Stockholders’ equity (Capital Deficiency)    
Common Stock, $0.0001 par value; Authorized - 120,000,000 shares as of March 31, 2024 and December 31, 2023. Issued and outstanding-59,998,342 shares as of March 31, 2024 and 45,979,930 shares as of December 31, 2023. 4 3
Additional paid in capital 170,749 166,048
Accumulated deficit (180,297) (162,970)
Total stockholders’ equity (Capital Deficiency) (9,544) 3,081
Total liabilities and stockholders’ equity $ 81,606 $ 25,029